Form 4 for ABT Abbott Laboratories
Accepted 2026-04-29 17:09:00 ET · period of report 2026-04-28 · accession 0001783147-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-04-29 17:09 | 2026-04-28 | ABT | Moreland Mary K | EVP | I - Discretionary | $94.41 | +5,314 | 17.2K | +45% | +$501.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2026-04-28 | I | A | 5,314 | $94.41 | 17,159 | I Profit Sharing Trust | — | — | (F1) Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026. |